Europa · Agencias y tiempo real · Reuters US Markets

Obesity drug developer Corxel to go public in US via SPAC deal

Publicado por Reuters US Markets · Reino Unido hace 11 h

Obesity drug developer Corxel Pharmaceuticals will go public in the US through a merger with special purpose acquisition company Amanat Acquisition ‌Corp , the companies…

Leer el artículo completo en Reuters US Markets Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.reuters.com)

Obesity drug developer Corxel to go public in US via SPAC deal

También te puede interesar

Fed expected to hold rates amid accelerating inflation ahead of November US midterms

Japanese companies compensate users as cyberattacks buffet economy

FTSE 100 rises as falling oil prices boost risk appetite

Saudi Arabia to store oil in Singapore to bolster Asia supply security

Fed to hit pause on rate hikes, but maybe not for long

Fed to hit pause on rate hikes, but maybe not for long

Obesity drug developer Corxel to go public in US via SPAC deal

Compartir

También te puede interesar

Fed expected to hold rates amid accelerating inflation ahead of November US midterms

Japanese companies compensate users as cyberattacks buffet economy

FTSE 100 rises as falling oil prices boost risk appetite

Saudi Arabia to store oil in Singapore to bolster Asia supply security

Fed to hit pause on rate hikes, but maybe not for long

Fed to hit pause on rate hikes, but maybe not for long